• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unveiling the Impact of Sarcopenia on Short-term Mortality in Hospitalized Liver Cirrhosis Patients.

作者信息

Merli Manuela, Khan Saniya

机构信息

Department of Translational and Precision Medicine, Sapienza University of Rome, Roma, Italy.

出版信息

J Clin Exp Hepatol. 2023 Nov-Dec;13(6):931-933. doi: 10.1016/j.jceh.2023.09.004. Epub 2023 Sep 14.

DOI:10.1016/j.jceh.2023.09.004
PMID:37975049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10643520/
Abstract
摘要

相似文献

1
Unveiling the Impact of Sarcopenia on Short-term Mortality in Hospitalized Liver Cirrhosis Patients.揭示肌肉减少症对肝硬化住院患者短期死亡率的影响。
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):931-933. doi: 10.1016/j.jceh.2023.09.004. Epub 2023 Sep 14.
2
A Prospective Study of Prevalence and Impact of Sarcopenia on Short-term Mortality in Hospitalized Patients with Liver Cirrhosis.一项关于肌肉减少症在肝硬化住院患者中的患病率及其对短期死亡率影响的前瞻性研究。
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):946-954. doi: 10.1016/j.jceh.2023.05.001. Epub 2023 May 10.
3
Compound Sarcopenia in Hospitalized Patients with Cirrhosis Worsens Outcomes with Increasing Age.肝硬化住院患者的复合性肌少症随年龄增长会使预后恶化。
Nutrients. 2021 Feb 18;13(2):659. doi: 10.3390/nu13020659.
4
Coexistent GLIM-Defined Malnutrition and Sarcopenia Increase the Long-Term Mortality Risk in Hospitalized Patients with Decompensated Cirrhosis.共存的 GLIM 定义的营养不良和肌少症增加了失代偿期肝硬化住院患者的长期死亡风险。
Ann Nutr Metab. 2023;79(5):423-433. doi: 10.1159/000534152. Epub 2023 Sep 19.
5
Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality.NASH 肝硬化患者移植前肌少症不会影响再住院或死亡率。
J Clin Gastroenterol. 2019 Oct;53(9):680-685. doi: 10.1097/MCG.0000000000001109.
6
Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis.存在肌肉减少症及其变化率与肝硬化患者的长期死亡率独立相关。
J Korean Med Sci. 2018 Oct 31;33(50):e299. doi: 10.3346/jkms.2018.33.e299. eCollection 2018 Dec 10.
7
Bedside assessment of sarcopenia in hospitalized patients with liver cirrhosis: Magnitude and clinical implications.肝硬化住院患者肌少症的床边评估：程度和临床意义。
Indian J Gastroenterol. 2024 Aug;43(4):821-831. doi: 10.1007/s12664-024-01642-x. Epub 2024 Jul 26.
8
Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study.肝硬化患者的肌肉减少症和生理低呼吸商：一项前瞻性对照研究。
J Appl Physiol (1985). 2013 Mar 1;114(5):559-65. doi: 10.1152/japplphysiol.01042.2012. Epub 2013 Jan 3.
9
[Risk factors of cirrhosis combined with sarcopenia and their impact on clinical outcomes].[肝硬化合并肌肉减少症的危险因素及其对临床结局的影响]
Zhonghua Gan Zang Bing Za Zhi. 2020 Jan 20;28(1):53-57. doi: 10.3760/cma.j.issn.1007-3418.2020.01.013.
10
Impact of Sarcopenia on Short-Term Complications and Survival After Liver Transplant.肌肉减少症对肝移植术后短期并发症及生存的影响
Exp Clin Transplant. 2022 Oct;20(10):917-924. doi: 10.6002/ect.2022.0293.

本文引用的文献

1
A Prospective Study of Prevalence and Impact of Sarcopenia on Short-term Mortality in Hospitalized Patients with Liver Cirrhosis.一项关于肌肉减少症在肝硬化住院患者中的患病率及其对短期死亡率影响的前瞻性研究。
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):946-954. doi: 10.1016/j.jceh.2023.05.001. Epub 2023 May 10.
2
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis.肌肉减少症对肝硬化患者生存的影响：一项荟萃分析。
J Hepatol. 2022 Mar;76(3):588-599. doi: 10.1016/j.jhep.2021.11.006. Epub 2021 Nov 14.
3
Sarcopenia and frailty in decompensated cirrhosis.失代偿期肝硬化中的肌肉减少症和衰弱。
J Hepatol. 2021 Jul;75 Suppl 1(Suppl 1):S147-S162. doi: 10.1016/j.jhep.2021.01.025.
4
Evidence-Based Aerobic Exercise Training in Metabolic-Associated Fatty Liver Disease: Systematic Review with Meta-Analysis.基于证据的有氧运动训练在代谢相关脂肪性肝病中的应用：系统评价与荟萃分析
J Clin Med. 2021 Apr 13;10(8):1659. doi: 10.3390/jcm10081659.
5
Emerging Treatment Options for Sarcopenia in Chronic Liver Disease.慢性肝病中肌肉减少症的新兴治疗选择
Life (Basel). 2021 Mar 17;11(3):250. doi: 10.3390/life11030250.
6
Sarcopenia in Cirrhosis: Fallout on Liver Transplantation.肝硬化中的肌肉减少症：对肝移植的影响。
J Clin Exp Hepatol. 2020 Sep-Oct;10(5):467-476. doi: 10.1016/j.jceh.2019.12.003. Epub 2019 Dec 31.
7
Sarcopenia in cirrhosis: A practical overview.肝硬化中的肌肉减少症：实用概述。
Clin Med (Lond). 2020 Sep;20(5):489-492. doi: 10.7861/clinmed.2020-0089.
8
Exercise and physical activity in cirrhosis: opportunities or perils.肝硬化患者的运动与体力活动：机遇还是风险？
J Appl Physiol (1985). 2020 Jun 1;128(6):1547-1567. doi: 10.1152/japplphysiol.00798.2019. Epub 2020 Apr 2.
9
Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration.肝性脑病与肌肉减少症：同一代谢改变的两面
J Clin Exp Hepatol. 2019 Jan-Feb;9(1):125-130. doi: 10.1016/j.jceh.2018.04.007. Epub 2018 May 5.
10
Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score.肌肉减少症对肝硬化预后价值的影响：超越肝静脉压力梯度和 MELD 评分。
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):860-870. doi: 10.1002/jcsm.12333.